|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-3-4
|
|
pubmed:abstractText |
Giant cell tumor of bone (GCT) is a benign tumor with a significant tendency to recur locally and rarely to produce pulmonary metastases. It is characterized by the presence of multinucleated osteoclast-like giant cells together with mononuclear spindle-shaped cells. Few prognostic markers have been reported to predict the clinical outcome of GCT patients, so is very important to find the factor that can be implicated in its potential aggressiveness.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PLAUR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Urokinase Plasminogen...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BalladelliAA,
pubmed-author:BenassiM SMS,
pubmed-author:BertoniFF,
pubmed-author:FerrariCC,
pubmed-author:GamberiGG,
pubmed-author:GigliMM,
pubmed-author:MercuriMM,
pubmed-author:PazzagliaLL,
pubmed-author:PiccoVV,
pubmed-author:PonticelliFF,
pubmed-author:RagazziniPP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
498-503
|
|
pubmed:dateRevised |
2009-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:14998856-Bone Neoplasms,
pubmed-meshheading:14998856-Bone Resorption,
pubmed-meshheading:14998856-Giant Cell Tumor of Bone,
pubmed-meshheading:14998856-Humans,
pubmed-meshheading:14998856-Immunoenzyme Techniques,
pubmed-meshheading:14998856-Interleukin-6,
pubmed-meshheading:14998856-Neoplasm Proteins,
pubmed-meshheading:14998856-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:14998856-Prognosis,
pubmed-meshheading:14998856-RNA, Messenger,
pubmed-meshheading:14998856-RNA, Neoplasm,
pubmed-meshheading:14998856-Receptors, Cell Surface,
pubmed-meshheading:14998856-Receptors, Urokinase Plasminogen Activator,
pubmed-meshheading:14998856-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:14998856-Tumor Markers, Biological,
pubmed-meshheading:14998856-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone.
|
|
pubmed:affiliation |
Laboratory of Oncologic Research, Department of Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Bologna, Italy. gabriella.gamberi@ior.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
